The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging
- PMID: 24253338
- DOI: 10.1007/s00404-013-3081-8
The special role of ultrasound for screening, staging and surveillance of malignant ovarian tumors: distinction from other methods of diagnostic imaging
Abstract
Ovarian cancer is the most aggressive gynecologic malignancy, with a 5-year survival rate ranging around 40%. A crucial factor influencing the prognosis is early detection of a suspicious mass and referral to a gynecologic oncology center for further diagnosis, staging and debulking surgery. Here, we present the different imaging methods ultrasound (US), magnetic resonance imaging, computer tomography (CT) and 18F-fluoro-deoxyglucose positron emission tomography (PET)/CT that are used for the characterization, diagnosis, staging and surveillance of ovarian cancer. In this review, we focus on US and discuss in detail the advantages and the limitations, as well as the appropriate indications for each of the individual imaging techniques.
Comment in
-
The mass cannot be classified as malignant.Arch Gynecol Obstet. 2015 Mar;291(3):473-4. doi: 10.1007/s00404-014-3556-2. Epub 2014 Nov 29. Arch Gynecol Obstet. 2015. PMID: 25432543 No abstract available.
-
Comment on the letter: the mass cannot be classified as malignant.Arch Gynecol Obstet. 2015 Mar;291(3):475. doi: 10.1007/s00404-014-3558-0. Arch Gynecol Obstet. 2015. PMID: 25488156 No abstract available.
Similar articles
-
Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.Gynecol Oncol. 2010 Mar;116(3):389-94. doi: 10.1016/j.ygyno.2009.10.059. Epub 2009 Nov 18. Gynecol Oncol. 2010. PMID: 19926121 Clinical Trial.
-
Ovarian cancer: detection and radiologic staging.Clin Obstet Gynecol. 2009 Mar;52(1):73-93. doi: 10.1097/GRF.0b013e3181961625. Clin Obstet Gynecol. 2009. PMID: 19179862 Review.
-
MRI, CT, and PET/CT for ovarian cancer detection and adnexal lesion characterization.AJR Am J Roentgenol. 2010 Feb;194(2):311-21. doi: 10.2214/AJR.09.3522. AJR Am J Roentgenol. 2010. PMID: 20093590 Review.
-
PET/CT in the staging of patients with a pelvic mass suspicious for ovarian cancer.Gynecol Oncol. 2013 Dec;131(3):694-700. doi: 10.1016/j.ygyno.2013.08.020. Epub 2013 Aug 27. Gynecol Oncol. 2013. PMID: 23988417
-
Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.Invest Radiol. 2014 Aug;49(8):524-31. doi: 10.1097/RLI.0000000000000050. Invest Radiol. 2014. PMID: 24637584
Cited by
-
Simple laboratory score improves the preoperative diagnosis of adnexal mass.Tumour Biol. 2016 Apr;37(4):4343-9. doi: 10.1007/s13277-015-4280-7. Epub 2015 Oct 23. Tumour Biol. 2016. PMID: 26499778
-
Murine model for non-invasive imaging to detect and monitor ovarian cancer recurrence.J Vis Exp. 2014 Nov 2;(93):e51815. doi: 10.3791/51815. J Vis Exp. 2014. PMID: 25407815 Free PMC article.
-
A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.Front Cell Dev Biol. 2021 Aug 30;9:712196. doi: 10.3389/fcell.2021.712196. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34527671 Free PMC article.
-
In 2014, can we do better than CA125 in the early detection of ovarian cancer?World J Biol Chem. 2014 Aug 26;5(3):286-300. doi: 10.4331/wjbc.v5.i3.286. World J Biol Chem. 2014. PMID: 25225597 Free PMC article. Review.
-
Borderline ovarian tumors and diagnostic dilemma of intraoperative diagnosis: could preoperative He4 assay and ROMA score assessment increase the frozen section accuracy? A multicenter case-control study.Biomed Res Int. 2014;2014:803598. doi: 10.1155/2014/803598. Epub 2014 Nov 5. Biomed Res Int. 2014. PMID: 25431767 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical